SCHEMBL22817636

SCHEMBL22817636

c1ccc(-c2ccccc2N(c2ccccc2)c2cccc3oc4c5ccccc5c(-c5ccccc5)cc4c23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.36
▸ CDC14B O60729 1/20 0.33
▸ CDC14A Q9UNH5 1/20 0.33
▸ GGPS1 O95749 1/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP1B1 Q16678 2/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ PRKDC P78527 3/20 0.31
▸ GSK3B P49841 2/20 0.31
▸ CDK1 P06493 1/20 0.31
▸ CCNB1 P14635 1/20 0.31
▸ CDK5 Q00535 1/20 0.31
▸ CDK5R1 Q15078 1/20 0.31
▸ CRHR1 P34998 1/20 0.31
▸ PTGES2 Q9H7Z7 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ CSF1R P07333 1/20 0.30
▸ PDGFRB P09619 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ KIT P10721 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22818357 0.97 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A2
SCHEMBL22817988 0.97 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A2
SCHEMBL22817669 0.97 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A2
SCHEMBL27393174 0.95 ALOX5 (0.36) ALOX5CDC14BCDC14AGGPS1CYP1A2
SCHEMBL22817684 0.95 ALOX5 (0.36) ALOX5CDC14BCDC14AGGPS1CYP1A2
SCHEMBL22817960 0.95 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A2
SCHEMBL22818196 0.95 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A2
SCHEMBL22817931 0.95 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A2
SCHEMBL22818019 0.95 ALOX5 (0.35) ALOX5CDC14BCDC14AGGPS1PRKDC
SCHEMBL22817658 0.95 ALOX5 (0.38) ALOX5CDC14BCDC14AGGPS1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024111923-A1 ORGANIC LIGHT-EMITTING DEVICE, AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER 엘티소재주식회사 2024-05-30 — — WO disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20230329025-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-12 — — US disclosed
US-20230329025-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-12 — — US disclosed
WO-2023190597-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE 出光興産株式会社 2023-10-05 — — WO disclosed
WO-2023096225-A1 HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER, COMPRISING SAME 엘티소재주식회사 2023-06-01 — — WO disclosed
EP-3757095-A2 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT Materials Co., Ltd. (KR) 2020-12-30 — — EP disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885CDC14B 589/4885CDC14A 484/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885CDC14B 589/4885CDC14A 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback